Mieko Kanai

647 citations
13 papers · 538 indexed · h-index 9
Topics
Eicosanoids and Hypertension Pharmacology (4 papers)Steroid Chemistry and Biochemistry (4 papers)Cancer therapeutics and mechanisms (3 papers)
Partner nations
JapanUnited States

In The Last Decade

Mieko Kanai

11 papers receiving 475 citations

Peers

Mieko Kanai
Comparison fields: 5 of 72
  • Molecular Biology 351
  • Oncology 207
  • Biochemistry 94
  • Biotechnology 77
  • Pharmacology 70
Replace Nina Seiwert with:
Nina Seiwert Germany
Tzu‐Wen Lien Taiwan
John Giannaras United States
Yulia Maxuitenko United States
Michael Carducci United States
Juan A. Velasco United States
Yen-Chiu Lin-Lee United States
Yinglan Jin South Korea
John T. Piper United States
Tomomi Noguchi‐Yachide Japan
Mieko Kanai relative to Nina Seiwert Germany Nina Seiwert's profile →
Citations per field
00.5×4.3×
Nina Seiwert · 1×
Citations per year

Countries citing papers authored by Mieko Kanai

Since Specialization
Citations

This map shows the geographic impact of Mieko Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieko Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieko Kanai more than expected).

Fields of papers citing papers by Mieko Kanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieko Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieko Kanai. The network helps show where Mieko Kanai may publish in the future.

Co-authorship network of co-authors of Mieko Kanai

This figure shows the co-authorship network connecting the top 25 collaborators of Mieko Kanai. A scholar is included among the top collaborators of Mieko Kanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieko Kanai. Mieko Kanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1
The Word Book
0
2 77
3 1
4
Chikuma gendai bungaku taikei
1
5 42
6 27
7 87
8 1
9 49
10 30
11 188
12 17
13 18

About Mieko Kanai

Mieko Kanai is a scholar working on Biochemistry, Pharmacology and Microbiology, having authored 13 papers that have together received 538 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (4 papers), Steroid Chemistry and Biochemistry (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Biochemistry (94 citations), Biotechnology (77 citations) and Pharmacology (70 citations). Mieko Kanai has collaborated with scholars based in Japan and United States. Frequent co-authors include Takashi Sügimura, Masanao Miwa, Tadashi Watabe, Atsushi Oikawa, Hiroko Tohda, Naok̆i Ozawa, M. Isobe, Masakazu Isobe, Tomoko Kondo and Akira Inoue. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Extremophiles.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026